About
Digi Bio develops an AI-driven, single-cell digital biomanufacturing platform that uses automated microfluidics and advanced analytics to measure and track individual cell behavior and therapy performance in real time, aiming to accelerate and optimize cell-based therapies.
Explore Digi Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.